secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2021-12-10T23:59:59+00:00
Accession:  0001161697-21-000572
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical expects FY2021 revenue $23.0M-$23.2M; Q4 to show sequential growth
-------------------------------------------------------------------------------

- Q4 2021 expected to be the fourth consecutive quarter of positive sequential revenue growth.
- Full year 2021 revenue guidance of $23.0 million to $23.2 million.
- Domestic SCIg market expected to recover to mid-to-high single digits in 2022.
- Company expects its domestic SCIg revenue growth to be slightly ahead of the market recovery.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169721000572/0001161697-21-000572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169721000572/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-21-000572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer